Who owns LYRA THERAPEUTICS INC?
- Ticker: LYRA
- CUSIP Number: 55234l204
Tip: Access positions for across all investors
Analyze quarterly positions in Lyra Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lyra Therapeutics stock
Who bought or sold LYRA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sabby Management | 175k | $540k | 37% | Dec 2025 |
|
| Tower Research Capital | 2.2k | $6.7k | 310% | Dec 2025 |
|
| Jones Financial Companies, L.L | 210.00 | $647.010000 | 0% | Dec 2025 |
|
| Brian McDonald | 23.00 | $71.001000 | 0% | Dec 2025 |
|
| Advisor Group Holdings | 22.00 | $67.001000 | 0% | Dec 2025 |
|
| Global Retirement Partners | 15.00 | $46.000500 | 100% | Dec 2025 |
|
| CWM | 1.00 | $0 | -96% | Dec 2025 |
|
Who sold out of Lyra Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Group | Sep 2025 | 29k | $190k |
| Ikarian Capital | Dec 2025 | 21k | $65k |
| DRW Holdings | Dec 2025 | 17k | $52k |
| Geode Capital Management | Dec 2025 | 12k | $38k |
| Artia Global Partners | Dec 2025 | 8.8k | $27k |
| BlackRock | Dec 2025 | 2.4k | $7.4k |
| Royal Bank of Canada | Sep 2025 | 1.3k | $10k |
| UBS Group | Dec 2025 | 675.00 | $2.0k |
| FMR | Sep 2025 | 406.00 | $2.7k |
| EverSource Wealth Advisors | Dec 2025 | 338.00 | $1.0k |
| Morgan Stanley | Dec 2025 | 334.00 | $1.0k |
| SBI Securities | Dec 2025 | 80.00 | $246.000000 |
| Jpmorgan Chase & Co | Sep 2025 | 27.00 | $178.000200 |
| Bryn Mawr Trust | Dec 2025 | 20.00 | $62.000000 |
| Bnp Paribas Arbitrage, Snc | Dec 2025 | 16.00 | $49.000000 |
| IFP Advisors | Dec 2025 | 1.00 | $3.000000 |